Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

AIMS: Dapagliflozin and exenatide reduce body weight by differing mechanisms. Dual therapy with these agents reduces body weight, adipose tissue volume, glycaemia and systolic blood pressure (SBP) over 24 weeks. Here, we examined these effects over 1 year in obese adults without diabetes. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundkvist, Per, Pereira, Maria J., Katsogiannos, Petros, Sjöström, C. David, Johnsson, Eva, Eriksson, Jan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575470/
https://www.ncbi.nlm.nih.gov/pubmed/28345814
http://dx.doi.org/10.1111/dom.12954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575470/
https://www.ncbi.nlm.nih.gov/pubmed/28345814
http://dx.doi.org/10.1111/dom.12954

Ejemplares similares